Gene Therapy Market Research Reports & Industry Analysis
Gene Therapy Industry Research & Market Reports
-
Cell and Gene Therapy CROs Market, 2018-2030
... more than 25 such advanced therapy medicinal products are available in the market; examples of recently approved therapies include Alofisel® (2018), LUXTURNA™ (2017), YESCARTA™ (2017), Kymriah™ (2017) and INVOSSA™ (2017). In addition, over 500 cell ... Read More
-
Global Gene Therapy Partnering Terms and Agreements 2010 to 2018
... the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value The Global Gene Therapy ... Read More
-
Gene Editing and Gene Therapy Breakthroughs Propelling Mainstream Treatments
... Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme replacement therapies, usually prescribed for inherited diseases, to correct the root cause ... Read More
-
Global Gene Therapy Market 2018-2022
... and cardiovascular. It is the usage of modified gene injected into the patient’s body primarily through virus as a vector. This transmitted gene reaches the intended site to kill or treat the infected cell, thus ... Read More
-
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pip Review, H2 2018
... (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pip Review, H2 2018 Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Prot Read More
-
Duchenne Muscular Dystrophy: KOL Insight [2018]
... known cure and few treatment options. Since 2014, two antisense oligonucleotide therapies [Exondys 51 (Sarepta Therapeutics) and Translarna (PTC Therapeutics)] have been approved but how are they faring on the market? Find out how key ... Read More
-
Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing
... antigen receptor T-cells, or CAR T-cells) or RNA therapy platforms. Delivery technologies covered include AAV, adenovirus, lentivirus, retrovirus, other viral and nonviral. Disease areas covered include cardiology, oncology, ophthalmology, hematology, musculoskeletal, neurology, rare diseases and ... Read More
-
Growth Insights for the Direct-to-Consumer Genetic Testing Market, Forecast to 2022
... genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the requirement of a prescription from a healthcare provider. The tests can be purchased online from distribution channels such ... Read More
-
Viral Vector Manufacturing Market by Type (Retrovirus, Gammaretrovirus, AAV), Disease (Cancer, Infectious Disease, Genetic Disorders), Application (Gene Therapy, Vaccinology), End User (Biotech companies, Research Institutes) - Global Forecast to 2023
... manufacturing market is projected to grow at a CAGR of 20.0%.” The viral vector manufacturing market is expected to reach USD 815.8 million by 2023 from an estimated USD 327.8 million in 2018, at a ... Read More
-
Gene Therapy in CVMD
... stages, gene therapy aims to treat or alleviate a disease by genetically modifying the cells of a patient. This report focuses on gene therapies in development across the 8MM for cardiovascular and metabolic disorders, including ... Read More
-
Gene Therapy in Oncology
... of genes, gene segments, or oligonucleotides and target cells may be normal cells, cancerous cells, immune mediated cells, or pluripotent stem cells.Unlike conventional treatments such as chemotherapy, gene therapy combines reduced treatment duration (one time ... Read More
-
Gene Therapy R&D and Revenue Forecasts 2018-2028
... accounted for 68.7% of the gene therapy drug market. Visiongain estimated that gene therapy for rare diseases will be the driver for market growth in the second half of the forecast period. How this report ... Read More
-
Global Gene Therapies Market Research Report 2018
... focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Gene Therapies basics: definitions, classifications, applications ... Read More
-
Global Animal Genetics Market - Segmented by Type and Geography - Growth, Trends, and Forecast (2018 - 2023)
... period of 2018 - 2023. The growth of the overall animal growth promoters market can be contributed to the rising global meat demand, need for non-antibiotic growth promoters, rise in animal epidemic outbreaks, and demand ... Read More
-
Global virus filteration Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023
... global virus filtration market is expected to rise with the CAGR of about 12% during forecast period. Rising demand for biological products such as vaccines, cellular & gene therapy, etc. is one of the major ... Read More
-
Thalassemia Market Size, Share & Trends Analysis Report By Therapeutic Class (Iron Chelating Drugs), By Pipeline (Gene Therapy), By Region (U.S., U.K., France, Germany, Italy, Spain, Japan), And Segment Forecasts, 2016 - 2022
... global thalassemia market size is expected to be valued at USD 3.53 billion by 2022, as per a new report by Grand View Research, Inc., exhibiting a CAGR of 10.8% during the forecast period. Increase ... Read More
-
Cardiovascular Drugs: Global Markets to 2022
... industrywide assessment of the novel product launches, recent approvals, research and development pipeline, and blockbuster drugs. Strict regulations are imposed on cardiovascular drugs and the report discusses the regional regulatory landscape for these drugs. This ... Read More
-
Global Gene Therapy Market Analysis & Forecast to 2022
... Neurological, Ocular) and Forecast with CAGR Through 2022 Sub-Market Worth by Geography (Americas, Europe, RoW) and Forecast with CAGR Through 2022 Sub-Market Worth by Technology (Gene Product, Service, Viral Vectors) and Forecast with CAGR Through ... Read More
-
Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report
... The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations such as route of administration and target. Key questions answered in the report include What are the ... Read More
-
Gene Therapy for Age-related Macular Degeneration -A Pipeline Analysis Report
... and pre-clinical stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations such as therapy, route of administration, and target. Technavio’s market research analysts have predicted ... Read More
-
Gene Therapy for Mucopolysaccharidosis - A Pipeline Analysis Report
... development stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations including route of administration Key questions answered in the report include What are the gene ... Read More
-
Gene Therapy Market, (2nd Edition), 2018-2030
... China; since then, the domain has evolved significantly. The year 2017 was particularly eventful; despite the withdrawal of Glybera® from the European market in early 2017, the latter half of the year witnessed the approval ... Read More
-
The 2019-2024 World Outlook for Angiogenesis Inhibitors and Stimulators
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2019-2024 World Outlook for Gene Therapy
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Applications (Oncological Disorders, Rare Diseases, Cardiovascular Dis
... Infectious Disease, and Other Diseases) - Global Opportunity Analysis and Industry Forecast, 2017-2023 The global gene therapy market was valued at $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering ... Read More
